Marwan Noel Sabbagh

Direttore/Membro del Consiglio presso CERVOMED INC.

Patrimonio netto: - $ in data 30/04/2024

58 anni

22 relazioni

Health Technology

Consumer Services

Commercial Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
John Alam	M	62	CERVOMED INC. EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	14 anni
Sylvie Grégoire	M	62	CERVOMED INC. EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	14 anni
Brendan Hannah	M	39	QUINCE THERAPEUTICS, INC.	2 anni
Dirk Thye	M	54	QUINCE THERAPEUTICS, INC.	2 anni
Frank Zavrl	M	58	CERVOMED INC. EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	1 anni
William Tanner	M	65	CERVOMED INC. EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	1 anni
Robert Cobuzzi	M	59	CERVOMED INC.	1 anni
Jeffrey Poulton	M	56	CERVOMED INC. EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	1 anni
William Elder	M	41	CERVOMED INC.	1 anni
June Bray	F	70	QUINCE THERAPEUTICS, INC.	2 anni
Joshua Boger	M	73	CERVOMED INC.	-
Jane Hollingsworth	F	66	CERVOMED INC.	1 anni
Maureen M. Roden	F	-	QUINCE THERAPEUTICS, INC.	2 anni
Kelly Blackburn	F	60	CERVOMED INC.	1 anni
Gary Ward	M	-	QUINCE THERAPEUTICS, INC.	2 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Christopher Lowe	M	56	QUINCE THERAPEUTICS, INC.	3 anni
Caryn McDowell	F	54	QUINCE THERAPEUTICS, INC.	2 anni
Leslie Holsinger	M	58	QUINCE THERAPEUTICS, INC.	6 anni
Philip Low	M	76	QUINCE THERAPEUTICS, INC.	1 anni
Michael J. Detke	M	57	QUINCE THERAPEUTICS, INC.	4 anni
Karen Smith	M	56	QUINCE THERAPEUTICS, INC.	1 anni
Jill Davidson	F	67	CERVOMED INC.	-

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	22	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni